Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02904798 · ClinicalTrials.gov registry record · NA
The Effects of Visible Light on the Skin After Administration of Oral Polypodium Leucotomos
A NA study of Photodermatoses, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT02904798 is a NA study of Photodermatoses that has completed, run by Henry Ford Health System. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02904798, a NA study of Photodermatoses, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Polypodium Leucotomos Extract (PLE) is a tropical fern that has antioxidative, photoprotective, chemoprotective, anti-inflammatory, and immunomodulatory properties. The antioxidative effects of PL include inhibition and scavenging of free radicals, lipid peroxidation and reactive oxygen species (ROS) such hydrogen peroxide, superoxide anion, hydroxyl radical and singlet oxygen. Visible light (400-700 nm) causes pigmentation in melanocompetent individuals and induces DNA damage in the human skin through ROS production. The goal of this study is to determine whether the administration of oral PLE has an effect on the development of visible light induced pigmentation.
Conditions Studied
Interventions
- DRUG Polypodium Leucotomos
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2017-04-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02904798
The ClinicalTrials.gov registry entry for NCT02904798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Photodermatoses appearing as the primary indexed condition, and to 1 intervention - of which Polypodium Leucotomos is the first listed.
NCT02904798 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02904798 about?
NCT02904798 is a clinical study titled "The Effects of Visible Light on the Skin After Administration of Oral Polypodium Leucotomos". Polypodium Leucotomos Extract (PLE) is a tropical fern that has antioxidative, photoprotective, chemoprotective, anti-inflammatory, and immunomodulatory properties. The antioxidative effects of PL include inhibition and scavenging of free radicals, lipid peroxidation and reactive oxygen species (ROS...
What is the current status of trial NCT02904798?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-07-01. Estimated completion is 2017-04-23.
What conditions does trial NCT02904798 study?
This clinical trial studies the following conditions: Photodermatoses.
What interventions are being tested in trial NCT02904798?
The interventions under investigation include: Polypodium Leucotomos (DRUG).
Who is sponsoring clinical trial NCT02904798?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02904798 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.